Kung Winston
Insider CIK 1666963 · CRBP Director · PMVP COO, CFO · JANX Director · AVBP Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 15,500 | — | $0 | 15,500 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2026-06-11 | 2026-06-12 | 5,500 | — | $0 | 11,750 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2026-06-10 | 2026-06-11 | 2,026 | $7.91 | $16.0K | 12,140 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2026-05-19 | 2026-05-21 | 12,300 | — | $0 | 12,300 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2026-05-19 | 2026-05-21 | 3,800 | — | $0 | 14,166 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 140,000 | — | $0 | 140,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 11,667 | — | $0 | 11,667 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2025-06-11 | 2025-06-13 | 3,750 | — | $0 | 6,250 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2025-05-30 | 2025-06-02 | 4,800 | — | $0 | 10,366 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | A Award deriv | 2025-02-03 | 2025-02-14 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2024-08-16 | 2024-08-20 | 5,566 | — | $0 | 5,566 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2024-08-16 | 2024-08-20 | 5,566 | — | $0 | 5,566 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 8,350 | — | $0 | 8,350 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2024-06-26 | 2024-06-28 | 2,500 | — | $0 | 2,500 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2023-05-12 | 2023-05-15 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift | 2022-11-25 | 2023-01-30 | 2,560 | — | $0 | 10,600 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2022-09-21 | 2022-09-22 | 9,375 | — | $0 | 9,375 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2022-09-21 | 2022-09-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise deriv | 2022-04-20 | 2022-04-21 | 4,000 | — | $0 | 210,034 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise | 2022-04-20 | 2022-04-21 | 4,000 | $3.22 | $12.9K | 10,600 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2022-02-10 | 2022-02-28 | 104,400 | — | $0 | 104,400 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift | 2021-12-30 | 2022-02-08 | 2,725 | — | $0 | 6,600 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise deriv | 2021-08-19 | 2021-08-20 | 5,000 | — | $0 | 214,034 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise | 2021-08-19 | 2021-08-20 | 5,000 | $3.22 | $16.1K | 6,600 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise deriv | 2021-08-03 | 2021-08-04 | 4,500 | — | $0 | 219,034 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-08-03 | 2021-08-04 | 4,500 | $33.82 | $152.2K | 1,600 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise | 2021-08-03 | 2021-08-04 | 4,500 | $3.22 | $14.5K | 6,100 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise deriv | 2021-07-08 | 2021-07-08 | 4,500 | — | $0 | 223,534 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-07-08 | 2021-07-08 | 4,500 | $33.75 | $151.9K | 1,600 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise | 2021-07-08 | 2021-07-08 | 4,500 | $3.22 | $14.5K | 6,100 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise deriv | 2021-06-04 | 2021-06-07 | 4,500 | — | $0 | 228,034 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-06-04 | 2021-06-07 | 4,500 | $33.75 | $151.9K | 1,600 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise | 2021-06-04 | 2021-06-07 | 4,500 | $3.22 | $14.5K | 6,100 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2021-05-12 | 2021-06-08 | 50,337 | — | $0 | 50,337 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise deriv | 2021-05-03 | 2021-05-04 | 4,500 | — | $0 | 232,534 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-05-03 | 2021-05-04 | 4,500 | $33.75 | $151.9K | 1,600 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise | 2021-05-03 | 2021-05-04 | 4,500 | $3.22 | $14.5K | 6,100 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise deriv | 2020-12-08 | 2020-12-31 | 1,600 | — | $0 | 237,034 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise | 2020-12-08 | 2020-12-31 | 1,600 | $3.22 | $5.2K | 1,600 | SEC↗ |